Global Radiosurgical System Market Size By Type (Linear Accelerator Based Therapies, Proton Beam Therapy), By Application (Clinics and Hospitals, Caring Centers), By Region, And Segment Forecasts, 202...

The Global Radiosurgical System Market was valued at USD 3.1 billion in 2023 and is projected to surpass USD 5.7 billion by 2031, growing at a CAGR of 8.2% during the forecast period of 2023-2031. Radiosurgery is a non-invasive medical procedure that utilizes precisely targeted radiation to treat tumors and other abnormalities. The increasing prevalence of cancer and neurological disorders, rising preference for minimally invasive procedures, and advancements in imaging and radiation delivery technologies are driving market growth. The growing adoption of robotic-assisted radiosurgery and integration of artificial intelligence (AI) in treatment planning are expected to further boost the market.

Market Drivers

1. Rising Prevalence of Cancer and Neurological Disorders

The growing incidence of brain tumors, arteriovenous malformations, and functional neurological disorders such as trigeminal neuralgia is fueling demand for advanced radiosurgical solutions. The rising cancer burden globally is increasing the demand for precise and effective treatment methods.

2. Technological Advancements in Radiosurgical Systems

The integration of AI-powered treatment planning, image-guided radiation therapy (IGRT), and robotic radiosurgery has improved accuracy and efficiency, reducing treatment time and minimizing side effects. Innovations such as real-time motion tracking and adaptive radiation therapy are enhancing patient outcomes.

3. Increasing Adoption of Minimally Invasive Procedures

Patients and healthcare providers are increasingly favoring non-invasive radiosurgery over traditional surgical methods due to reduced recovery time, lower risk of infections, and improved patient comfort. This is driving market expansion.

Market Restraints

1. High Cost of Radiosurgical Systems

The high initial investment and maintenance costs of advanced radiosurgery systems, such as Gamma Knife and CyberKnife, pose a challenge for hospitals, particularly in developing regions. The lack of affordability limits adoption rates.

2. Limited Availability of Skilled Professionals

The operation of radiosurgical systems requires highly trained medical professionals, including radiation oncologists, neurosurgeons, and physicists. A shortage of skilled specialists in certain regions may hinder market growth.

Market Opportunity

1. Expansion in Emerging Markets

Developing economies in Asia-Pacific, Latin America, and the Middle East are witnessing rapid healthcare infrastructure improvements. Increased investments in radiation oncology facilities and government initiatives supporting cancer treatment are opening new growth avenues.

2. Advancements in Robotic-Assisted Radiosurgery

Robotic radiosurgery systems, such as CyberKnife by Accuray, are gaining traction due to their ability to deliver highly precise radiation doses while compensating for patient movement. Further innovations in robotics and AI are expected to improve treatment efficiency.

Market by System Type Insights

1. Gamma Knife Radiosurgery

Dominated the market in 2023 due to its efficacy in treating brain tumors, vascular malformations, and neurological disorders.

Preferred for stereotactic radiosurgery (SRS) applications.

2. Linear Accelerator (LINAC)-Based Radiosurgery

Expected to grow at the highest CAGR due to its versatility in treating both brain and body tumors.

Incorporation of image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART) is boosting adoption.

3. Proton Beam Radiosurgery

Gaining popularity due to its ability to minimize radiation exposure to healthy tissues.

Ideal for treating pediatric cancer patients and complex tumor locations.

Market by End-use Insights

1. Hospitals

Largest segment, holding over 50% market share in 2023.

Increasing installation of LINAC and Gamma Knife systems in hospitals with comprehensive cancer care centers.

2. Specialty Clinics & Ambulatory Surgical Centers

Fastest-growing segment due to the rising demand for outpatient cancer treatments.

The shift toward shorter hospital stays and improved patient convenience is driving segment expansion.

Market by Regional Insights

1. North America

Largest market share in 2023 due to high adoption rates of advanced radiosurgery technologies, presence of leading medical device manufacturers, and a strong reimbursement framework.

The U.S. dominates the region, supported by a high number of cancer treatment centers and R&D investments.

2. Europe

Second-largest market driven by the presence of leading healthcare infrastructure and regulatory support for advanced radiotherapy technologies.

Countries like Germany, France, and the UK are major contributors.

3. Asia-Pacific

Expected to witness the highest CAGR during the forecast period.

Factors such as rising healthcare expenditure, increasing cancer prevalence, and expanding medical tourism in China, India, and Japan are propelling market growth.

Competitive Scenario

Leading players in the Global Radiosurgical System Market include:

Elekta AB (Gamma Knife)

Accuray Incorporated (CyberKnife)

Varian Medical Systems (a Siemens Healthineers company)

Brainlab AG

Ion Beam Applications (IBA)

ViewRay Inc.

Mevion Medical Systems

ZAP Surgical Systems, Inc.

Companies are focusing on technological advancements, strategic partnerships, and mergers & acquisitions to expand their market presence.

Scope of Work – Global Radiosurgical System Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.7 billion

CAGR (2023-2031) 8.2%

Key Segments by System Type Gamma Knife, LINAC-Based, Proton Beam

Key Segments by End-Use Hospitals, Specialty Clinics & Ambulatory Surgical Centers

Leading Region North America

Key Players Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, IBA, ViewRay Inc., Mevion Medical Systems, ZAP Surgical Systems

Growth Drivers Rising prevalence of cancer, technological advancements, increasing adoption of minimally invasive procedures

Opportunities Expansion in emerging markets, advancements in robotic-assisted radiosurgery

Key Market Developments

February 2023: Accuray Incorporated introduced an upgraded CyberKnife system with AI-driven treatment planning, enhancing precision and reducing session times.

July 2023: Varian Medical Systems launched a next-generation proton therapy system aimed at improving treatment accuracy while reducing side effects.

November 2023: Elekta AB partnered with a leading U.S. cancer center to implement cloud-based AI-driven radiosurgery planning solutions.

March 2024: ViewRay Inc. expanded its MRI-guided radiosurgery portfolio, enhancing real-time imaging capabilities.

FAQs

1. What is the current market size of the Global Radiosurgical System Market?

The Global Radiosurgical System Market was valued at USD 3.1 billion in 2023.

2. What is the major growth driver of the Radiosurgical System Market?

The increasing prevalence of cancer and neurological disorders, along with technological advancements in radiosurgery systems, is the major growth driver.

3. Which is the largest region during the forecast period in the Radiosurgical System Market?

North America dominates the market due to high adoption rates of advanced radiosurgery technologies and strong reimbursement support.

4. Which segment accounted for the largest market share in the Radiosurgical System Market?

The Gamma Knife segment held the largest share in 2023, primarily due to its effectiveness in treating brain tumors and neurological disorders.

5. Who are the key market players in the Radiosurgical System Market?

Key players include Elekta AB, Accuray Incorporated, Varian Medical Systems, Brainlab AG, IBA, ViewRay Inc., Mevion Medical Systems, and ZAP Surgical Systems.

This detailed report provides insightful analysis into the Global Radiosurgical System Market, covering key growth trends, market drivers, opportunities, and competitive dynamics.